Fusion of Dynactin 1 (DCTN1) to ALK in Inflammatory Myofibroblastic Tumor

被引：0
|
作者：
Wang, X.
Krishnan, C.
Nguyen, E.
Mayer, K. J.
Oliveira, J. L.
Yi, J. E.
Yang, P.
Yaszemski, M. J.
Maran, A.
Erickson-Johnson, M. R.
Oliveira, A. M.
机构：
[1] Mayo Clin, Rochester, MN USA
[2] Dells Childrens Med Ctr Cent Texas, Austin, TX USA
[3] Mayo Clin & Mayo Fdn, Mayo Med Sch, Rochester, MN 55905 USA
来源：
LABORATORY INVESTIGATION | 2011年 / 91卷
关键词：
D O I：
暂无
中图分类号：
R-3 [医学研究方法]; R3 [基础医学];
学科分类号：
1001 ;
摘要：
81
引用
收藏
页码：22A / 23A
页数：2
相关论文
共 50 条
  • [41] Point mutations of the p150 subunit of dynactin (DCTN1) gene in amyotrophic lateral sclerosis
    Muench, C
    Sedlmeier, R
    Meyer, T
    Homberg, V
    Sperfeld, AD
    Kurt, A
    Prudlo, J
    Peraus, G
    Hanemann, CO
    Stumm, G
    Ludolph, AC
    ANNALS OF NEUROLOGY, 2004, 56 : S30 - S30
  • [42] The dynactin subunit DCTN1 controls osteoclastogenesis via the Cdc42/PAK2 pathway
    Yong Deok Lee
    Bongjun Kim
    Suhan Jung
    Haemin Kim
    Min Kyung Kim
    Jun-Oh Kwon
    Min-Kyoung Song
    Zang Hee Lee
    Hong-Hee Kim
    Experimental & Molecular Medicine, 2020, 52 : 514 - 528
  • [43] ALK-ATIC fusion in urinary bladder inflammatory myofibroblastic tumor
    Debiec-Rychter, M
    Marynen, P
    Hagemeijer, A
    Pauwels, P
    GENES CHROMOSOMES & CANCER, 2003, 38 (02): : 187 - 190
  • [44] Pulmonary Inflammatory Myofibroblastic Tumor Expressing a Novel Fusion, PPFIBP1-ALK: Reappraisal of Anti-ALK Immunohistochemistry as a Tool for Novel ALK Fusion Identification
    Takeuchi, Kengo
    Soda, Manabu
    Togashi, Yuki
    Sugawara, Emiko
    Hatano, Satoko
    Asaka, Reimi
    Okumura, Sakae
    Nakagawa, Ken
    Mano, Hiroyuki
    Ishikawa, Yuichi
    CLINICAL CANCER RESEARCH, 2011, 17 (10) : 3341 - 3348
  • [45] The dynactin subunit DCTN1 controls osteoclastogenesis via the Cdc42/PAK2 pathway
    Lee, Yong Deok
    Kim, Bongjun
    Jung, Suhan
    Kim, Haemin
    Kim, Min Kyung
    Kwon, Jun-Oh
    Song, Min-Kyoung
    Lee, Zang Hee
    Kim, Hong-Hee
    EXPERIMENTAL AND MOLECULAR MEDICINE, 2020, 52 (03): : 514 - 528
  • [46] Newly Identified Dynactin Variant (DCTN1 p.Tyr78His) in a Patient with Perry Syndrome
    Cierny, Marek
    Hooshmand, Sam
    Fee, Dominic
    Brennan, Ryan
    NEUROLOGY, 2020, 94 (15)
  • [47] Autonomic failures in Perry syndrome with DCTN1 mutation
    Ohshima, Sachiko
    Tsuboi, Yoshio
    Yamamoto, Akifumi
    Kawakami, Masato
    Farrer, Matthew J.
    Kira, Jun-ichi
    Shii, Hirofumi
    PARKINSONISM & RELATED DISORDERS, 2010, 16 (09) : 612 - 614
  • [48] Inflammatory Myofibroblastic Tumor of the Testis With Confirmed ALK-1 Gene Rearrangement
    Hickman, Richard
    Alexander, Melissa
    Melamed, Jonathan
    Deng, Fang-Ming
    AMERICAN JOURNAL OF CLINICAL PATHOLOGY, 2015, 144 : A313 - A313
  • [49] Inflammatory myofibroblastic tumor of kidney with expression of ALK-1: Case report
    Amarti, Afaf
    Fatemi, Hind
    MODERN PATHOLOGY, 2006, 19 : 76 - 76
  • [50] Characterization of DCTN1 genetic variability in neurodegeneration
    Vilarino-Gueell, C.
    Wider, C.
    Soto-Ortolaza, A. I.
    Cobb, S. A.
    Kachergus, J. M.
    Keeling, B. H.
    Dachsel, J. C.
    Hulihan, M. M.
    Dickson, D. W.
    Wszolek, Z. K.
    Uitti, R. J.
    Graff-Radford, N. R.
    Boeve, B. F.
    Josephs, K. A.
    Miller, B.
    Boylan, K. B.
    Gwinn, K.
    Adler, C. H.
    Aasly, J. O.
    Hentati, F.
    Destee, A.
    Krygowska-Wajs, A.
    Chartier-Harlin, M. -C.
    Ross, O. A.
    Rademakers, R.
    Farrer, M. J.
    NEUROLOGY, 2009, 72 (23) : 2024 - 2028
12345